New president for UK and Éire Glaucoma Society announced
Professor Gus Gazzard has taken up the role, Glaucoma UK said
05 May 2022
A new president and president-elect have been announced for the UK and Éire Glaucoma Society (UKEGS).
UKEGS, part of Glaucoma UK, welcomed professor of ophthalmology at UCL and director of glaucoma service at Moorfields Eye Hospital, Gus Gazzard, as its new president on 1 May.
Gazzard succeeds Professor Pete Shah as UKEGS president.
Speaking about his appointment, Gazzard said: “I will continue to work closely with Glaucoma UK to raise awareness of glaucoma – especially in those most at risk from losing vision. This includes minority ethnic communities and those who are socio-economically disadvantaged.”
He added: “I shall also seek to foster closer collaboration between all eye care professionals – for example, encouraging more regular eye health checks in the relatives of those affected by glaucoma.”
The new president-elect is Nishani Amerasinghe, a consultant ophthalmic surgeon who works in Winchester and Southampton.
UKEGS is a non-profit national scientific society, which aims to promote the exchange of knowledge between glaucoma specialists, stimulate glaucoma research, and protect the interests of people who are either living with glaucoma or at risk of developing it.
Joanne Creighton, Glaucoma UK’s Chief Executive, said, “We are delighted to welcome Gus and Nishani as president and president-elect of UKEGS.
“The Society plays a pivotal role in the development of glaucoma care in the UK, by bringing glaucoma specialists together to share their knowledge and expertise of the disease.”
She added: “We look forward to working closely with Gus and Nishani in their new leadership roles, and to building on the society’s previous successes of promoting knowledge exchange. The vital collaborative opportunities which UKEGS provides mean that, together, we can make a difference to the lives of people living with glaucoma.”
Lead image: Professor Gus Gazzard
Comments (0)
You must be logged in to join the discussion. Log in